Panelists discuss how caregivers can navigate the initial shock of a myeloma diagnosis by seeking reliable information from ...

Panelists discuss how Alan Plisskin's multiple myeloma diagnosis began with severe back and hip pain, progressed through life ...

The FDA has approved a biosimilar of pertuzumab which is indicated for multiple breast cancer settings. The FDA has approved ...

The FDA has granted approval to the menin inhibitor ziftomenib (Komzifti) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) harboring NPM1 mutations with no ...

She emphasized the essential role nurses play in ethics committees, where they have the opportunity to represent patients’ ...

What she initially dismissed as stress or a complication of her existing hormone treatments with Turner syndrome soon led to ...

Laura J. Zitella, MS, RN, ACNP-BC, AOCN, explains that later cytopenias should be monitored in patients undergoing CAR T-cell ...

Integrative oncology is a patient-centered approach to cancer care that looks at the whole patient and combines their ...

The FDA has approved subcutaneous daratumumab and hyaluronidase-fihj (Darzalex Faspro) for use in patients with high-risk ...

This is where the “third opinion” comes in: the patient’s own perspective (or care partner’s) that is surfaced and then validated by the APP. In the uncertainty of a cancer journey, this distinct, ...

Catherine Boyles, RN, OCN, explains how to help patients help themselves when preparing for appointments.

Among lymphoma survivors experiencing chronic fatigue, a multidisciplinary intervention program has been found to have a ...